Article

Safety and Efficacy of Disulfiram in Hospitalized Patients with Moderate COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial

2023-10-26

Abstract excerpt

<h4>OBJECTIVES</h4> Disulfiram, a low-cost generic drug used for alcohol dependence, holds the potential to mitigate disease progression in patients with moderate COVID-19 by targeting inflammasomes. This study aimed to evaluate the clinical efficacy and safety of disulfiram when administered alongside standard of care for the treatment of hospitalized individuals with moderate COVID-19. <h4>DESIGN</h4> A randomiz...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4781d636-ace4-5d4b-a0c1-dc47d7970256
DOI: 10.1101/2023.10.25.23297554

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Safety and Efficacy of Disulfiram in Hospitalized Patients with Moderate COVID-19: A Randomized, Double-Blind, Placebo-Controlled TrialDOI 10.1101/2023.10.25.23297554Read

Disulfiram associated with lower risk of Covid-19: a retrospective cohort studySemantic proximity Read

Efficacy and Safety of AYUSH-64 in COVID-19: A Systematic Review and Meta-AnalysisSemantic proximity Read

Effects of Pycnogenol<sup>®</sup>in post-COVID-19 condition (PYCNOVID): A single-center, placebo controlled, quadruple-blind, randomized trialSemantic proximity Read

Metformin on Time to Sustained Recovery in Adults with COVID-19: The ACTIV-6 Randomized Clinical TrialSemantic proximity Read

Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild-to-Moderate COVID-19: The SCORPIO-SR Randomized Clinical TrialSemantic proximity Read

CHOLINERGIC AGONISTS AGAINST COVID-19 IN HUMANS. RESULTS FROM A RANDOMIZED OPEN LABEL PILOT TRIALSemantic proximity Read

Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical TrialSemantic proximity Read

Bromhexine, for Post Exposure COVID-19 Prophylaxis: A Randomized, Double-Blind, Placebo Control TrialSemantic proximity Read

Clinical and Non-clinical Proof of Concept Supporting the Development of RJX As an Adjunct to Standard of Care Against Severe COVID-19Semantic proximity Read

Coadministration of AYUSH 64 as an adjunct to Standard of Care in mild and moderate COVID-19: A randomised, controlled, multicentric clinical trialSemantic proximity Read

Treatment with Arbidol and Moxifloxacin in Ordinary and Severe Adult Patients Infected with COVID-19Semantic proximity Read

Comparison Between Healthcare Professionals And The General Population On Parameters Related To Natural Remedies Used During The COVID-19 PandemicSemantic proximity Read